Adverse Reactions Up 134 Percent In Hubei
This article was originally published in PharmAsia News
Hubei Provincial FDA announced there were 11,089 reports of adverse reactions to drugs in 2008, up 134.99 percent from 2007. The significant increase represents heightened awareness of adverse reactions. Statistics show that 55.99 percent of the reports are related to antibiotics, which highlights the abuse and misuse of antibiotics in China. According to the "Drug Administration Law" and "Statute Governing the Report and Administration of Adverse Reaction to Drugs," pharmaceutical manufacturers, companies and medical institutions are all responsible for reporting adverse events, yet only 0.2 percent of the reports were filed by drug makers. The authorities plan on targeting them for future improvement. (Click here for more
You may also be interested in...
CV Defense, the second launch in the firm’s new immune-support line (without cannabidiol), is built around palmitoylethanolamide and other nutrients and botanicals to “optimize immune response.” CV Sciences touts the immunity range as complementary to its PlusCBD brand, which is in the process of rolling out dozens of new products in updated packaging.
Public Company Edition: Codiak, Kiromic, Aligos and Opthea have fallen below their initial public offering values, while Tarsus and Praxis are trading higher. Also, 5AM, MPM and Cormorant took biotech SPACs public and Evotec led recent non-IPO financings with a €250m private placement.
US, EU and Canadian authorities recently discussed their approaches to rolling reviews of CMC applications for coronavirus vaccines.